Welcome to the e-CCO Library!

P109: Risk of cervical cancer in incident Ulcerative Colitis during the first 10 years after diagnosis: A nationwide population-based study
Year: 2022
Source: ECCO'22
Authors: Kim, J.(1);Kim, H.(2);Park, S.C.(2);Lee, J.K.(3);Kang, D.R.(3);Kim, S.Y.(2);Kim, H.S.(2);Kim, H.M.(2);
Created: Friday, 11 February 2022, 3:52 PM
P109: Using baseline Peripheral blood mononuclear cell (PBMC) transcriptomics of Crohn Disease patients receiving Ustekinumab treatment as a tool to assess potential response at 1 year
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Granot, M.(1); Braun, T.(2); Efroni, G.(2); Fudim, E.(2);Yavzori, M.(2);Haj, O.(3); Ben-Horin, S.(3);Kopylov, U.(3);Haberman Ziv, Y.(1)*;
Created: Friday, 14 July 2023, 10:48 AM
P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Huhn1, M. Herrero San Juan1, B. Melcher2, C. Dreis1, K. Schmidt1, J.M. Pfeilschifter1, M. Vieth2, J. Stein3, H.H. Radeke1

Created: Thursday, 30 January 2020, 10:12 AM
P110: Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bernardo D.*1, Mora-Gutierrez I.1, Marin A.c.1, Díaz-Guerra A.1, Caminero-Fernández R.2, Caldas M.2, De la Morena F.2, Jiménez M.2, Chaparro M.1, Gisbert J.P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P110: Cigarette smoke modulates the effect of dextran sulfate sodium–induced colitis on a subpopulation of T-cells in blood and colon in mice
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Daniluk*1, U. Daniluk2, M. Rusak3, J. Reszec4, M. Dabrowska3, A. Dabrowski1

Created: Friday, 22 February 2019, 9:49 AM
P110: Fibroblast activation protein is strongly expressed in intestinal fibrosis in inflammatory bowel disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lartey, D.(1,2)*;van Roest, M.(1);Verhoeff, J.(1,3);Grootjans, J.(1,2);Buskens, C.(4);van der Bilt, J.(4,5);Wildenberg, M.(1);D'Haens, G.(2);Löwenberg, M.(2);
Created: Friday, 14 July 2023, 10:48 AM
P110: Inter-rater validity of a new scoring index for Crohn’s disease (Crohn's disease activity in capsule endoscopy)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Omori*1, K. Yasuhiro1, S. Murasugi1, H. Kambayashi1, T. Hara1, A. Ito1, M. Yonezawa1, S. Nakamura1, K. Tokushige1

Created: Friday, 22 February 2019, 9:41 AM
P110: Risk Factors of Clinical Relapses in Pediatric Luminal Crohn’s Disease, a Retrospective Cohort Study
Year: 2022
Source: ECCO'22
Authors: Sassine, S.(1,2);Djani, L.(1,2);Cambron-Asselin, C.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Qaddouri, M.(1,2);Fadela-Zekhnine, S.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P110: Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey
Year: 2021
Source: ECCO'21 Virtual
Authors: Dotson, J.(1);Hunter, T.(2);Lukanova, R.(3);Crandall, W.(4);Komocsar, W.(4);Larkin, A.(4);Meakin, S.(3);Otley, A.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P110: TIGIT expression identifies circulating CD38+ effector T cells with immune regulatory properties whose frequencies at diagnosis predict disease course of paediatric IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Joosse1*, C. Menckeberg1, L.F. de Ruiter1, H. Raatgeep1, L.A. van Berkel1, Y. Simons-Oosterhuis1, M. Joosse2, R.W. Hendriks2, R.M. Hoogenboezem3, T. Cupedo3, L. de Ridder4, J. Escher4, S. Veenbergen1, J.N. Samsom1

Created: Thursday, 21 February 2019, 9:14 AM
P111 Elucidation of inflammatory infiltration of myenteric plexus in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.J. Wiese, A. Fascì, A.A. Kühl, B. Siegmund, M.S. Prüß, M. Schumann

Created: Thursday, 30 January 2020, 10:12 AM
P111: Clinical validation of a blood-based prognostic biomarker in Inflammatory bowel disease; towards personalised medicine in IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Lyons*1

Created: Friday, 22 February 2019, 9:41 AM
P111: Cross-sectional imaging is highly sensitive in detecting endoscopic post-operative recurrence in Crohn’s disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Bachour, S.(1);Shah, R.S.(1);Lyu, R.(2);Nakamura, T.(3);Shen, M.(3);Li, T.(3);Rieder, F.(1);Cohen, B.(1);Qazi, T.(1);Lashner, B.(1);Achkar, J.P.(1);Philpott, J.(1);Lightner, A.(4);Holubar, S.(4);Regueiro, M.(1);Dane, B.(5);Baker, M.(6);Axelrad, J.(7);Click, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P111: Differences in therapies and intestinal resection rates between adult and elderly onset Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Alexakis*1, S. Saxena2, V. Chhaya1, E. Cecil2, R. Pollok1

Created: Friday, 22 February 2019, 9:49 AM
P111: Efficacy of a novel long-acting lipidated interleukin-22, alone and in combination with anti-TNF treatment, in a murine chronic DSS colitis model
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Van De Bunt, M.(1)*;D'Alessio, S.(2);Norrild, J.C.(3);Kjølbye, A.L.(1);Jorgensen, R.(1);
Created: Friday, 14 July 2023, 10:48 AM
P111: Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT): A possible new target in inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Travelli1*, G. Colombo1, C. Porta1,2, F. Malavasi3, A.A. Genazzani1

Created: Thursday, 21 February 2019, 9:14 AM
P111: Gut barrier markers in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Nguyen, A.(1);Sparrow, M.P.(2);Moore, G.(3);Gibson, P.R.(2);
Created: Friday, 11 February 2022, 3:52 PM
P111: The anti-inflammatory effect of a serine protease inhibitor in a chronic colitis transfer model is mediated by the suppression of Th1 cell differentiation
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Van Spaendonk H.*1, Francque S.1,2, De Man J.1, De Winter B.1

Created: Wednesday, 20 February 2019, 10:36 AM
P112 Body composition and resting energy expenditure in IBD patients receiving biological therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Vranesic Bender1, L. Cengic2, D. Ljubas Kelecic1, I. Karas1, A. Grbin Hodžić3, V. Domislović3, M. Brinar3, M. Juričić1, Ž. Krznarić3

Created: Thursday, 30 January 2020, 10:12 AM
P112: Impact of the SARS-COV2 pandemic on patients with inflammatory bowel disease - Preliminary results of a prospective, single-center study
Year: 2021
Source: ECCO'21 Virtual
Authors: Martins Figueiredo, L.(1);Correia, F.(1);Rafael, M.A.(1);Lourenço, L.(1);Oliveira, A.M.(1);C. Branco, J.(1);Santos, L.(1);Martins, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM